Twist Bioscience Launched A Portfolio Of RNA Sequencing Tools, Including Twist RNA Exome, Twist RNA Library Prep Kit, Twist Ribosomal RNA & Hemoglobin Depletion Kit, And Custom Target Enrichment Capabilities For RNA & Whole Transcriptome Sequencing
Portfolio Pulse from Benzinga Newsdesk
Twist Bioscience has launched a portfolio of RNA sequencing tools, including Twist RNA Exome, Twist RNA Library Prep Kit, Twist Ribosomal RNA & Hemoglobin Depletion Kit, and custom target enrichment capabilities for RNA & whole transcriptome sequencing.
May 22, 2023 | 12:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Twist Bioscience's new portfolio of RNA sequencing tools may boost its market position and drive revenue growth.
The launch of Twist Bioscience's new RNA sequencing tools expands its product offerings and enhances its competitive edge in the biotech industry. This could lead to increased demand for its products, resulting in higher revenues and a positive impact on its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100